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Purpose: This study compared the total antioxidant status (TAS) and superoxide dismutase (SOD) activity in the saliva of peri-
odontally compromised patients before and after scaling and root planing (SRP) to assess their diagnostic utility. 
Methods:  Severe chronic periodontitis patient (test group) and subjects with no attachment loss, sites showing a 3 mm or more 
probing depth and a sulcus bleeding index < 10% (control group) were enrolled in this study. Saliva sampling and clinical exam-
ination were performed at one week, one month and 3 months after SRP. The TAS and SOD activity in each patient’s saliva was 
measured for the comparative analysis between the groups. 
Results:  In the test group, the TAS decreased directly after SRP. With time, it increased slightly and was relatively unchanged 
compared to the baseline. In the control group, the TAS also decreased immediately after SRP but increased gradually with time 
until 3 months. The SOD activity in the test and control subjects decreased immediately after SRP until 1 month. At 3 months, the 
SOD activity had increased. Both groups had a similar profile of SOD activity. However, the SOD activity of the control group 
was significantly higher than that of the test group at each point in time (P < 0.05).
Conclusions: There was a significant difference in the total salivary antioxidant level between the periodontitis and healthy 
or gingivitis (control) group during the experiment period. The total antioxidant level in the saliva was higher in the patients 
with severe chronic periodontitis than the healthy or gingivitis control before SRP. The SOD activity of the periodontitis pa-
tients was lower than the control at each time point. These findings conclusively reveal the possible use of saliva as a diagnos-
tic tool for periodontal health.
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INTRODUCTION
Periodontal disease can be caused by immune reactions be-
tween pathogenic bacteria and the host. Specific bacteria in-
duce the release of cytokines, such as interleukin-6 and tu-
mor necrosis factor-α, which increase the number of poly-
morphonuclear leukocytes and their activation [1]. Reactive 
oxygen species (ROS), such as superoxide anion, hydroxyl rad-
ical, nitrous oxide and hydrogen peroxide, can be produced 
via the bacteria-host mediated pathway inducing tissue inju-
ry. At the same time, polymorphonuclear leukocytes produce 
and increase the concentration of ROS, resulting in oxidative 
damage to the periodontal tissue [2]. These destructive mech-
anisms include DNA damage, lipid peroxidation, protein dam-
age, and the oxidation of enzymes [3,4].
The host has the ability to eliminate ROS and inhibit the tis-
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sue destruction caused by inflammatory reactions by releas-
ing defensive substances (e.g. antioxidants) in the humor and 
tissues.
Antioxidants include superoxide dismutase (SOD), uric acid, 
ascorbic acid, α-tocopherol, glutathione and albumin. One 
important antioxidant, SOD catalyzes the dismutation of the 
superoxide anion, defending the cells against the hazardous 
effects of ROS [5]. There are few reports on the relationship 
between SOD and inflammation in oral tissues, and the re-
sults that have been reported are controversial. SOD activity 
increases remarkably in irreversible pulpitis while it decreas-
es significantly in the gingival tissue close to the deep peri-
odontal pocket [6-8].
Saliva contains water, proteins, electrolytes, gingival sulcu-
lar fluid, serum, cells, bacteria, food residue, and organic mol-
ecules. It includes a range of antioxidants and is affected by 
inflammatory reactions. A weakened antioxidative defense 
system in the gingival crevicular fluid (GCF) accelerates the 
effects of periodontal disease [9,10]. Previous research focused 
on the immune mechanisms of the secretory immunoglob-
ulin A and protein-enzymatic defense system [11]. Recently, 
research into various enzymatic salivary systems as antioxi-
dants has clarified the importance of other defense systems 
in the saliva [10,12,13]. Chapple et al. [9] reported that patients 
with periodontal diseases had a low total antioxidant status 
(TAS). Liskmann et al. [12] reported that the TAS was lower in 
the peri-implant disease group than healthy group. On the 
other hand, Moore et al. [14] reported no significant differ-
ence in the TAS level in the saliva between patients with 
periodontal disease and a normal group. There have been no 
published reports on the relationship between periodontal 
disease and the antioxidants in saliva, or on the potential use 
of saliva as a diagnostic tool. 
This study compared the TAS and SOD activity in the saliva 
of periodontally diseased patients before and after scaling and 
root planing (SRP) to determine its diagnostic utility. 
MATERIALS AND METHODS
Study population
The test group included 14 patients diagnosed with severe 
chronic periodontitis in the Department of Periodontology, 
Chonnam National University Hospital from May to October 
in 2008. The patients diagnosed with severe chronic periodon-
titis had more than two areas with a 5 mm or more probing 
depth (PD) in the quadrant and bone loss > 30% of the root 
length on the radiographs. In a control group, 12 patients who 
did not have attachment loss or sites showing a PD of 3 mm 
or more with a sulcus bleeding index (SBI) < 10% were enrolled. 
Both the control and test groups had more than 20 function-
al teeth. 
The exclusion criteria were as follows: people with other 
medical conditions that could affect the results, people who 
had taken anti-inflammatory drugs or antibiotics within the 
previous 3 months, pregnant women, people who use mouth-
washes regularly, and people who had taken vitamins in the 
previous 3 months.
There were some drop-outs during the study resulting in a 
final test group and control group consisting of 7 subjects (3 
males, 4 females; average age, 50.5 years [range, 31 to 66 
years]) and 7 subjects (3 males, 4 females; average age, 31.7 
years [range, 26 to 49 years]), respectively. All subjects in the 
test group were diagnosed with severe chronic periodontitis 
and there was one smoker. Their periodontal condition was 
good and there was only one smoker (Table 1). This study was 
approved by the Chonnam National University Hospital In-
stitutional Review Board (IRB No. 1-2008-04-046), and a con-
sent agreement was obtained from all the participants. 
Methods
At the initial examination, the test and control group mem-
bers were selected after a clinical and radiographic examina-
tion. After 1 week, saliva sampling, clinical examination, as well 
as SRP, were performed in each group. One week, one month 
and 3 months later saliva sampling and clinical examination 
were again performed. 
The test group took tooth-brushing instruction (TBI) 1 week 
after scaling, and root planing was carried out for each quad-
rant under local anesthesia with a 1 week interval. In the con-
trol group, SRP was performed and TBI only was carried out 
after 1 week (Fig. 1).
Clinical examination
The clinical examinations were performed after taking the 
saliva samples. All procedures were carried out by a calibrat-
Table 1.  Clinical data at the baseline (mean ± SD).
Parameters Controls
Patients with severe 
chronic periodontitis
N (males/females) 7 (3/4) 7 (3/4)
Age (yr) 31.7 ± 8.0 50.0 ± 12.5
Periodontal disease index
PD (mm) 2.4 ± 0.1 3.4 ± 0.5
CAL (mm) 2.4 ± 0.2 4.1 ± 0.4
PI
a) 11.0 ± 16.7 36.9 ± 32.2
SBI
b) 12.6 ± 13.8 44.1 ± 32.8
Smoking (smoker / non-smoker) 1/6 1/6
PD: probing depth, CAL: clinical attachment level, PI: plaque index, SBI: sulcus 
bleeding index.
a)Sum of PI, 
b)Sum of SBI.Journal of Periodontal
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ed examiner. The clinical examinations were performed be-
fore treatment, and 1 week, 1 month and 3 months after SRP. 
1) Plaque index
The plaque in the gingival margin was evaluated using the 
plaque index (PI) reported by Silness and Löe. The PIs were 
recorded on four tooth surfaces (mesial, distal, buccal, and 
lingual). The scores for the PI were:
  0: no plaque in the gingival area.
  1:   a film of plaque adhering to the free gingival margin and 
adjacent area of the tooth. The plaque could be recognized 
only by running a probe across the tooth surface.
  2:   moderate accumulation of soft deposits within the gingi-
val pocket and on the gingival margin and/or adjacent 
tooth surface that could be seen by the naked eye.
  3:   abundance of soft matter within the gingival pocket and/
or on the gingival margin and adjacent tooth surface.
2) Sulcus bleeding index
The level of gingival inflammation was evaluated using the 
SBI reported by Mühlemann and Son. The SBI was recorded 
on six tooth surfaces (mesio-buccal, buccal, disto-buccal, me-
sio-longual/palatal, lingual/palatal, and disto-lingual/palatal. 
The scores for the SBI were:
  0: no bleeding.
  1:   bleeding on probing with no change in color and no 
swelling.
  2:   bleeding on probing with a change in color and no swell-
ing or macroscopic edema.
    3:   bleeding on probing with a change in color and edema-
tous swelling.
  4:   bleeding on probing with a change in color due to inflam-
mation, edematous swelling with ulceration.
  5:   spontaneous bleeding, changes in color and marked swell-
ing with ulceration.
3) Probing depth and clinical attachment level
The PD was defined as the distance from the free gingival 
margin to the pocket base. The clinical attachment level (CAL) 
was defined as the sum of the distance from the cement-
enamel junction to the free gingival margin and pocket depth. 
All measurements were taken using a Williams probe (23 W, 
Hu-Friedy, Chicago, IL, USA) with 0.5 mm units. The measure-
ments were recorded on six surfaces of each tooth (mesio-buc-
cal, buccal, disto-buccal, mesio-longual/palatal, lingual/palatal, 
and disto-lingual/palatal). The average measurements of all 
surfaces were taken.
 
Saliva sampling and evaluation of TAS
All the saliva samples were taken in the morning after an 
overnight fast. Before taking the samples, the subjects were 
asked not to drink any beverage except for water. Saliva sam-
ples were taken before treatment, and 1 week, 1 month and 3 
months after treatment.
1) Saliva sampling 
In order to take the stimulated saliva samples, the subjects 
were asked to chew a gum base for 1 minute to stimulate the 
saliva glands and spit into a cooled 50 mL disposable tube with 
a lowered head position. More than 5 mL of stimulated saliva 
was collected. The tubes were combined with 50 μL of Com-
plete
TM protease inhibitor cocktail (Rosche, Manheim, Ger-
many) and centrifuged at 2,000 g for 15 minutes. After centrif-
ugation, the supernatant solution was separated and placed in 
a 1 mL tube. The tubes were stored at -20°C. The samples were 
analyzed within 4 weeks.
2) Analysis of TAS
The TAS was analyzed using an ImAnOx (TAS) Kit (Immun-
diagnostik AG, Bensheim, Germany) according to the manu-
facturer’s instructions, and measured at 450 nm using an ELISA 
reader (Model-680
®, Bio-Rad, Osaka, Japan). The TAS was de-
termined from the manufacturer’s formula using the values 
from ELISA. The units of measurement were μM.
 
3) Analysis of SOD activity
The SOD activity was evaluated using an SOD Assay Kit - 
WST (Dojindo Laboratories, Kumamoto, Japan) according to 
the manufacturer’s instruction, and an ELISA reader (Mod-
el-680
®) at 450 nm. The SOD activity was obtained from the 
manufacturer’s formula using the values from ELISA. The 
unit of measurement was %. 
Statistical analysis
All measurements were recorded as the mean ± standard 
deviation. Statistical analysis was performed using SPSS (SPSS 
Figure 1.  Experimental protocol scheme. TBI: tooth-brushing in-
struction.
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Inc., Chicago, IL, USA). Two-way ANOVA was performed to 
compare the TAS and SOD activity of the control and test 
group according to the elapsed postoperative time. P < 0.05 was 
considered significant. 
RESULTS
Changes in clinical indices
The mean PD in the test group was 3.4, 2.8, and 2.4 mm at 
the baseline, 1 week and 1 month after treatment, respective-
ly, showing a decrease with time. The PD in the control group 
was 2.4, 2.2, and 2.4 mm at the baseline, 1 week, and 1 month 
after treatment, respectively. The PD in the control group de-
creased slightly 1 week after treatment but returned to the 
baseline at 1 month after treatment. The mean CAL in the test 
group was 4.1 mm, 3.6 mm, and 3.2 mm at baseline, 1 week and 
1 month after treatment, respectively, whereas the mean CAL 
in the control group was 2.4 mm, 2.2 mm, and 2.4 mm, respec-
tively. The average sum of the PI in the test group was 36.9, 8.1, 
2.7 at the baseline, 1 week, and 1 month after treatment, respec-
tively, showing a significant decrease, whereas the average sum 
of the PI in the control group was 11.0, 3.0, and 0.1, respective-
ly. The mean SBI in the test group was 44.1, 26.9, and 6.4 at the 
baseline, 1 week, and 1 month after treatment, respectively, 
whereas that in the control group was 12.6, 2.3, and 0.7, respec-
tively (Tables 2 and 3). Both groups showed a decrease but the 
Table 2.  Changes in clinical parameters (mean ± SD) of patients 
with severe chronic periotontitis (n = 7) after a periodontal treat-
ment.
Parameter Baseline
1 week after
 therapy
1 month after 
therapy
PD (mm) 3.4 ± 0.5 2.8 ± 0.5 2.4 ± 0.4
CAL (mm) 4.1 ± 0.4 3.6 ± 0.4 3.2 ± 0.5
PI
a) 36.9 ± 32.2 8.1 ± 7.3 2.7 ± 2.6
SBI
b) 44.1 ± 32.8 26.9 ± 23.4 6.4 ± 3.6
PD: probing depth, CAL: clinical attachment level, PI: plaque index, SBI: sulcus 
bleeding index.
a)Sum of PI, 
b)Sum of SBI.
Table 3.  Changes in clinical parameters (mean ± SD) of the controls 
(n = 7) after periodontal treatment.
Parameter Baseline
1 week after 
therapy
1 month after 
therapy
PD (mm) 2.4±0.1 2.2±0.1 2.4±0.1
CAL (mm) 2.4±0.1 2.2±0.1 2.4±0.1
PI
a) 11.0±16.7 3.0±3.6 0.1±0.4
SBI
b) 12.6±13.8 2.3±1.9 0.7±1.8
PD: probing depth, CAL: clinical attachment level, PI: plaque index, SBI: sulcus 
bleeding index.
a)Sum of PI, 
b)Sum of SBI.
Table 4. TAS in patients with severe chronic periodontitis and controls.
Patients Gender Age (years) Smoker
TAS level (μM)
Baseline 1 week after 
therapy
1 month after 
therapy
3 months after 
therapy
A Female 31 No 280.0 295.0 306.6 292.7
B Male 61 No 297.3 288.5 270.9 240.5
C Male 50 Smoker 373.0 350.2 356.6 370.2
D Female 56 No 353.0 329.9 287.9 358.6
E Male 37 No 347.0 238.5 386.0 378.3
F Female 49 No 325.1 266.5 291.0 286.1
G Female 66 No 374.7 383.7 371.9 361.1
Mean  50.0 ± 12.5 335.7 ± 36.6 307.5 ± 50.2 324.4 ± 46.0 326.8 ± 53.2
Controls Gender Age (years) Smoker Baseline
1 week after 
therapy
1 month after 
therapy
3 months after 
therapy
A Female 49 No 267.7 231.6 237.5 366.2
B Male 30 No 286.5 317.1 309.6 369.9
C Female 26 No 374.1 347.8 347.9 383.8
D Male 30 Smoker 333.8 320.6 367.4 343.9
E Female 33 No 261.1 219.4 298.5 392.0
F Female 26 No 211.9 211.9 221.2 357.9
G Male 28 No 243.7 214.9 270.5 348.5
Mean 31.7 ± 8.0 282.7 ± 55.1 260.1 ± 59.3 293.3 ± 54.2 366.0 ± 17.6
TAS: total antioxidant status.Journal of Periodontal
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test group showed a much larger reduction. 
Changes in TAS 
The mean TAS in the test group was 335.7 ± 33.6 μM, 307.5 ± 50.2 
μM, 324.4 ± 46.0 μM and 326.8 ± 53.2 μM at the baseline, 1 week, 
1 month, and 3 months after treatment, respectively. On the 
other hand, the mean TAS in the control group at the same 
time points was 282.7 ± 55.1 μM, 260.1 ± 59.3 μM, 293.3 ± 54.2 μM, 
and 366.0 ± 17.6 μM, respectively (Table 4).
TAS of the test group decreased immediately after scaling 
and remained relatively constant with time. TAS in the con-
trol group decreased immediately after scaling but increased 
gradually with time (Fig. 2).
Changes in SOD activity
The mean SOD activity of the test group was 41.4 ± 15.9%, 
36.4 ± 14.2%, 31.8 ± 22.9% and 53.2 ± 22.8% at the baseline, 1 week, 
1 month and 3 months after treatment, respectively. The cor-
responding values in the control group were 69.3 ± 14.5%, 58.7 ± 
 19.6%, 55.7 ± 14.5%, and 72.4 ± 7.3%, respectively (Table 5).
SOD activity in the severe chronic periodontitis patients and 
controls decreased immediately after SRP until 1 month but 
had increased again at 3 months. Both groups showed a sim-
ilar SOD activity profile, but the SOD activity of the control 
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Figure 2. Total antioxidant status (TAS) in severe chronic periodon-
titis patient group and control subject group. In the test group, the 
TAS decreased immediately after scaling and root planing (SRP). 
With time, there was little change. In the control group, the TAS was 
also decreased immediately after SRP but increased gradually there-
after. The TAS level of the control group increased 3 months after 
SRP. Error bars show standard deviation.
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Figure 3.  Superoxide dismutase (SOD) activities in severe chronic 
periodontitis patient group and control subject group. The SOD ac-
tivity in both groups decreased immediately after scaling and root 
planing until 1 month, and increased at 3 months. The SOD activity 
of the control group was higher than that of the test group at each 
time point. Error bars show standard deviation (
*P < 0.05).
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group was higher than that of the test group at each time point 
(P < 0.05) (Fig. 3).
DISCUSSION
Recently, there has been increasing interest in ROS, lipid per-
oxidation products, and antioxidant system in the etiology of 
periodontitis. Several studies in the periodontal field have ex-
amined saliva, GCF, and antioxidant conditions in the serum 
of periodontal patients.
Antioxidant agents can be classified into three groups accord-
ing to their function. First, preventive anti-oxidants inhibit the 
formation of free radicals, including SOD, carotenoids, catalase, 
glutathione peroxidase, transferrin, albumin, and haptoglobin. 
Secondly, radical-scavenging anti-oxidants, such as vitamin A, 
vitamin E, uric acid, ascorbic acid, albumin, and bilirubin, elim-
inate free radicals to inhibit the initiation and propagation of 
free radical damage. Subsequently, DNA repair enzymes, pro-
tease, transferase, lipase, and repair and de novo enzymes heal 
injuries and reorganize the structures of the membrane [15].
Among the many intrinsic antioxidants, SOD is a primary 
defending substance that protects cells from ROS by convert-
ing O2
- to H2O2. The SOD variants found in the human body 
can be divided into copper/zinc-SOD (Cu/Zn-SOD, SOD 1), Journal of Periodontal
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manganese SOD (Mn-SOD, SOD 2) and extracellular SOD 
(EC-SOD, SOD 3) according to the essential metal elements 
for their catalytic function [13,15]. Many studies have examined 
SOD and periodontitis. Na et al. [13] reported the expression 
of the SOD isoform associated with inflammatory gingival 
tissue. They carried out histological analysis on 33 chronic peri-
odontitis patients and 20 periodontally healthy subjects. The 
results indicated that the increase in SOD activity in the inflam-
matory periodontal tissue is associated with oxidative stimula-
tion in periodontitis patients [13].
Recently, there have been reports on the relationship between 
the TAS and periodontal diseases associated with the saliva, 
GCF, serum, and gingival tissue. Sculley and Langley-Evans 
[16] reported on the antioxidants in the saliva associated with 
periodontal conditions. They examined the antioxidant con-
ditions in the saliva associated with an increase in injury due 
to oxidation and reported that gingivitis and periodontitis are 
associated with a decreased antioxidant level in the saliva and 
increased oxidative injury. They also reported that low concen-
trations of antioxidants in GCF increase the neutrophil-induced 
injuries in the gingiva and adjacent structures. Brock et al. [17] 
measured the local and systemic total concentrations of an-
tioxidants in patients with periodontitis and periodontally 
healthy subjects. They concluded that the concentration of 
antioxidants in the GCF of patients with periodontitis is signif-
icantly lower than those in the control group. Cutando et al. [18] 
examined the relationship between the severity of periodontitis 
and melatonin, which is one of the antioxidants in saliva. They 
reported that the level of melatonin in the saliva decreased 
with increasing severity of periodontitis. Pussinen et al. [19] 
studied the relationship between periodontitis and the con-
centration of vitamin C in serum. They reported that patients 
with periodontitis, who were infected by Porphyromonas gin-
givalis, showed a lower vitamin C level in the serum than 
those not infected.
Meanwhile, Moore et al. [14] measured the amount of total 
antioxidant in the saliva of both periodontitis patients and 
periodontally healthy subjects, and reported no significant dif-
ferences between the two groups. Similarly, Chapple et al. [9] 
evaluated the serum and saliva samples of a diseased group 
and control group, and found a similar serum antioxidant level 
in both groups. Tsai et al. [20] reported that patients diagnosed 
with chronic periodontitis showed high levels of lipid peroxi-
dation in the GCF, which indicates the destruction of periodon-
tal tissue by increased ROS. Canakci et al. [21] examined the 
TAS and antioxidants in the serum, saliva, and GCF of wom-
en with periodontitis and preeclampsia. They reported that 
the SOD level and the glutathione peroxidase activity in the 
GCF and serum, and TAS in the saliva, GCF, and serum of fe-
male patients with preeclampsia and periodontitis were lower 
than those of the control group. However, they showed high 
concentrations of malondialdehyde in the GCF and serum. 
Table 5.  SOD activity in the patients with severe chronic periodontitis and controls.
Patients Gender Age (years) Smoker
SOD activity ( % )
Baseline 1 week after 
therapy
1 month after 
therapy
3 months after 
therapy
A Female 31 No 55.9 41.4 5.2 27.8
B Male 61 No 47.9 21.9 19.1 45.1
C Male 50 Smoker 31.6 31.6 11.4 54.2
D Female 56 No 46.8 41.5 53.2 21.4
E Male 37 No 15.7 21.1 65.3 76.9
F Female 49 No 30.7 34.4 23.1 74.7
G Female 66 No 60.9 62.7 45.8 72.6
Mean 50.0 ± 12.5 41.4±15.9 36.4 ± 14.2 31.8 ± 22.9 53.2 ± 22.8
Controls Gender Age (years) Smoker Baseline
1 week after 
therapy
1 month after 
therapy
3 months after 
therapy
A Female 49 No 75.7 49.7 59.9 80.4
B Male 30 No 91.9 42.5 66.9 71.4
C Female 26 No 43.6 28.1 26.3 74.3
D Male 30 Smoker 69.4 73.4 68.7 73.1
E Female 33 No 62.8 65.1 48.5 59.2
F Female 26 No 69.5 67.6 59.4 68.2
G Male 28 No 72.0 84.8 60.0 80.2
Mean 31.7 ± 8.0 69.3 ± 14.5 58.7 ± 19.6 55.7 ± 14.5 72.4 ± 7.3
SOD: superoxide dismutase.Journal of Periodontal
& Implant Science JPIS
SOD level in saliva can be used as a diagnostic marker for severe chronic periodontitis. 170
Ozmeric et al. [22] studied the level of arginase, one of the 
antioxidants in the saliva in periodontitis patients. They re-
ported that periodontitis patients showed high arginase ac-
tivity of glutathione peroxidase in the saliva.
In this study, although the changes in the TAS level and SOD 
activity were different among individuals, the measurements 
in both groups decreased immediately after non-surgical treat-
ment. The TAS level was higher in the test group than in the 
control group at the baseline. The TAS level of the control 
group increased 3 months after SRP, but the level in the severe 
chronic periodontitis patients had not changed after 3 months. 
The SOD activity in both groups showed a similar profile, a 
decrease until one month after SRP and an increase after 3 
months. The SOD activity of the control group was higher than 
that of the severe chronic periodontitis patients at each time 
point. 
In this study, before SRP, the TAS level in the test group was 
higher than that in the control group. These results are in con-
trast to those reported by Sculley and Langley-Evans [16]. Scul-
ley and Langely-Evans [16] reported that gingivitis and peri-
odontitis are associated with a decreased antioxidant level in 
the saliva and increased oxidative injury. It is possible that the 
TAS level in the saliva under chronic periodontitis is adapted 
to this pathological condition and is higher than under healthy 
conditions, and the test group was older than the control group. 
Therefore, when periodontitis is in the active state, the im-
mune defense mechanism is activated and the ROS released 
from the polymorphonuclear leukocytes increases, resulting 
in the release of antioxidants in the body with a concomitant 
increase in the antioxidant level in saliva. Interestingly, the TAS 
of the severe chronic periodontitis patients was not changed 
after treatment until 3 months, while the TAS of the healthy 
control group increased after treatment until 3 months. It was 
assumed that nonsurgical therapy did not improve the TAS in 
severe chronic periodontitis patients.
Although a small number of subjects were included in this 
study, this study did not show identical patterns between TAS 
and SOD activity after SRP. SOD is a component of the TAS 
in all aspects. In addition, the constitution and proportions of 
other antioxidants due to an increasing or decreasing tenden-
cy toward inflammation can complicate the changing antioxi-
dant patterns in the saliva. Previous studies selected simple 
periodontitis patients as test subjects without classifying them 
according to the different forms and severity of periodontitis 
specifically. The pathologic mechanisms were mixed with oth-
er periodontal conditions making it possible for an irregular 
antioxidative tendency to exist in the saliva. For this reason, 
in patients with severe chronic periodontitis, it is possible that 
the test group would show different patterns of total antioxi-
dants in the saliva. Moreover, there was a difference in the av-
erage age between the two groups. The TAS level and SOD 
activity can be affected by age. In addition, some smokers were 
included in both groups and there were different gender ra-
tios. The effects of smoking and the gender on the antioxidant 
level might complicate the changing antioxidant pattern in 
the saliva. 
Therefore, a longer-term study with more periodontitis pa-
tients and periodontally healthy subjects is required. In addi-
tion, more research will be needed to determine the effects 
of the types of periodontitis with different pathologic mech-
anisms, severity, age, smoking or non-smoking, and saliva flow 
rates in men and women on the antioxidant level. 
In conclusion, the periodontitis subjects showed a different 
profile of the salivary total antioxidant level than the healthy 
or gingivitis group. The total antioxidant level in the saliva was 
higher in the patients with severe chronic periodontitis than 
the healthy or gingivitis control before SRP. The profile of the 
SOD activity of the periodontitis patients was lower than the 
control at each time point. The salivary TAS and SOD activity 
were changed by SRP. These results suggest that the SOD level 
in the saliva can be used as a diagnostic marker of oxidative 
injury in severe chronic periodontitis patients.
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